The EUropean Network of National Schizophrenia Networks Studying Gene-Environment Interactions (EU-GEI): Incidence and First-Episode Case-Control Programme.


Journal

Social psychiatry and psychiatric epidemiology
ISSN: 1433-9285
Titre abrégé: Soc Psychiatry Psychiatr Epidemiol
Pays: Germany
ID NLM: 8804358

Informations de publication

Date de publication:
May 2020
Historique:
received: 15 07 2019
accepted: 06 01 2020
pubmed: 25 1 2020
medline: 26 9 2020
entrez: 25 1 2020
Statut: ppublish

Résumé

The EUropean Network of National Schizophrenia Networks Studying Gene-Environment Interactions (EU-GEI) study contains an unparalleled wealth of comprehensive data that allows for testing hypotheses about (1) variations in incidence within and between countries, including by urbanicity and minority ethnic groups; and (2) the role of multiple environmental and genetic risk factors, and their interactions, in the development of psychotic disorders. Between 2010 and 2015, we identified 2774 incident cases of psychotic disorders during 12.9 million person-years at risk, across 17 sites in 6 countries (UK, The Netherlands, France, Spain, Italy, and Brazil). Of the 2774 incident cases, 1130 cases were assessed in detail and form the case sample for case-control analyses. Across all sites, 1497 controls were recruited and assessed. We collected data on an extensive range of exposures and outcomes, including demographic, clinical (e.g. premorbid adjustment), social (e.g. childhood and adult adversity, cannabis use, migration, discrimination), cognitive (e.g. IQ, facial affect processing, attributional biases), and biological (DNA via blood sample/cheek swab). We describe the methodology of the study and some descriptive results, including representativeness of the cohort. This resource constitutes the largest and most extensive incidence and case-control study of psychosis ever conducted.

Identifiants

pubmed: 31974809
doi: 10.1007/s00127-020-01831-x
pii: 10.1007/s00127-020-01831-x
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

645-657

Subventions

Organisme : FP7 Ideas: European Research Council
ID : HEALTH-F2-2010-241909
Organisme : São Paulo Research Foundation
ID : 2012/0417-0

Investigateurs

Kathryn Hubbard (K)
Stephanie Beards (S)
Ulrich Reininghaus (U)
Giada Tripoli (G)
Simona A Stilo (SA)
Mara Parellada (M)
Laura Roldán (L)
Gonzalo López (G)
Mario Matteis (M)
Marta Rapado (M)
Emiliano González (E)
Covadonga Martínez (C)
Pedro Cuadrado (P)
José Juan Rodríguez Solano (JJR)
Angel Carracedo (A)
Javier Costas (J)
Enrique García Bernardo (EG)
Emilio Sánchez (E)
Ma Soledad Olmeda (MS)
Bibiana Cabrera (B)
Esther Lorente-Rovira (E)
Paz Garcia-Portilla (P)
Estela Jiménez-López (E)
Nathalie Franke (N)
Daniella van Dam (D)
Fabian Termorshuizen (F)
Elsje van der Ven (E)
Elles Messchaart (E)
Marion Leboyer (M)
Franck Schürhoff (F)
Grégoire Baudin (G)
Aziz Ferchiou (A)
Baptiste Pignon (B)
Stéphane Jamain (S)
Jean-Romain Richard (JR)
Thomas Charpeaud (T)
Anne-Marie Tronche (AM)
Flora Frijda (F)
Lucia Sideli (L)
Fabio Seminerio (F)
Crocettarachele Sartorio (C)
Giovanna Marrazzo (G)
Camila Marcelino Loureiro (CM)
Rosana Shuhama (R)
Mirella Ruggeri (M)
Sarah Tosato (S)
Chiara Bonetto (C)
Doriana Cristofalo (D)

Références

Schizophr Bull. 2014 Jul;40(4):729-36
pubmed: 24860087
Schizophr Res. 2018 Apr;194:86-90
pubmed: 28285025
Psychol Med. 2019 Jun;49(8):1378-1391
pubmed: 30282569
JAMA Psychiatry. 2018 Sep 1;75(9):901-910
pubmed: 29936532
World Psychiatry. 2011 Jun;10(2):138-51
pubmed: 21633691
Arch Gen Psychiatry. 2007 Jan;64(1):19-28
pubmed: 17199051
Lancet Psychiatry. 2019 May;6(5):427-436
pubmed: 30902669
Transl Psychiatry. 2016 May 03;6:e796
pubmed: 27138795
Schizophr Res. 2010 Jul;120(1-3):121-30
pubmed: 20303240
Schizophr Bull. 2012 Jun;38(4):661-71
pubmed: 22461484
Schizophr Bull. 2012 Nov;38(6):1118-23
pubmed: 23015685
World Psychiatry. 2016 Jun;15(2):93-102
pubmed: 27265690
Curr Opin Psychiatry. 2012 Mar;25(2):83-8
pubmed: 22249081
Br J Psychiatry. 1996 May;168(5):620-6
pubmed: 8733802
Lancet Psychiatry. 2015 Mar;2(3):233-8
pubmed: 26359901
Curr Opin Psychiatry. 2019 May;32(3):232-241
pubmed: 30724751
JAMA Psychiatry. 2018 Jul 1;75(7):678-686
pubmed: 29799917
Nature. 2014 Jul 24;511(7510):421-7
pubmed: 25056061
Br J Psychiatry. 2014 Aug;205(2):127-34
pubmed: 24723631
Br J Psychiatry. 2018 Apr;212(4):195-196
pubmed: 29557759
JAMA Psychiatry. 2018 Jan 1;75(1):36-46
pubmed: 29214289
Neuropsychiatr Dis Treat. 2016 Feb 16;12:357-73
pubmed: 26937191
Eur J Neurol. 2012 Jan;19(1):155-62
pubmed: 22175760
Acta Psychiatr Scand. 2018 Feb;137(2):88-97
pubmed: 29288491
Psychol Med. 2011 May;41(5):897-910
pubmed: 20663257
BMC Med. 2004 Apr 28;2:13
pubmed: 15115547
Am J Epidemiol. 2003 Aug 15;158(4):301-4
pubmed: 12915494
Am J Psychiatry. 2005 Sep;162(9):1652-7
pubmed: 16135624
JAMA Psychiatry. 2018 Dec 1;75(12):1211-1212
pubmed: 30304485
Psychol Med Monogr Suppl. 1992;20:1-97
pubmed: 1565705
Schizophr Bull. 2017 Oct 21;43(6):1251-1261
pubmed: 28521056

Auteurs

Charlotte Gayer-Anderson (C)

Department of Health Services and Population Research, Institute of Psychiatry, Psychology and Neuroscience, King's College London, 16 De Crespigny Park, London, SE5 8AF, England.

Hannah E Jongsma (HE)

PsyLife Group, Division of Psychiatry, University College London, London, England.
Department of Psychiatry, University of Cambridge, Cambridge, England.

Marta Di Forti (M)

Social, Genetic, and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, England.

Diego Quattrone (D)

Social, Genetic, and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, England.

Eva Velthorst (E)

Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, USA.
Seaver Autism Center for Research and Treatment, Icahn School of Medicine at Mount Sinai, New York, USA.
Early Psychosis Section, Department of Psychiatry, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands.

Lieuwe de Haan (L)

Early Psychosis Section, Department of Psychiatry, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands.

Jean-Paul Selten (JP)

Institute for Mental Health, GGZ Rivierduinen, Leiden, The Netherlands.
Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University Medical Centre, Maastricht, The Netherlands.

Andrei Szöke (A)

Institut National de la Santé et de la Recherche Médicale, U955, Equipe 15 Neuro-Psychiatrie Translationnelle, Créteil, France.
AP-HP, Pôle de Psychiatrie des Hôpitaux Universitaires Henri Mondor, Créteil, France.
Fondation FondaMental, Créteil, France.

Pierre-Michel Llorca (PM)

EA 7280 Npsydo, Université Clermont Auvergne, Clermont-Ferrand, France.

Andrea Tortelli (A)

Establissement Public de Santé, Maison Blanche, Paris, France.

Celso Arango (C)

Department of Child and Adolescent Psychiatry, Hospital General Universitario Gregorio Marañón, School of Medicine, Universidad Complutense, ISGM, CIBERSAM, Madrid, Spain.

Julio Bobes (J)

Department of Medicine, Psychiatry Area, School of Medicine, Universidad de Oviedo, Centro de Investigación Biomédica en Red de Salud Mental, Oviedo, Spain.

Miguel Bernardo (M)

Barcelona Clinic Schizophrenia Unit, Hospital Clinic, Department of Medicine, Neuroscience Institute, University of Barcelona, Institut d'Investigacions Biomèdiques, August Pi I Sunyer, Centro de Investigación Biomédica en Red de Salud Mental, Barcelona, Spain.

Julio Sanjuán (J)

Department of Psychiatry, School of Medicine, Universidad de Valencia, Centro de Investigación Biomédica en Red de Salud Mental, Valencia, Spain.

José Luis Santos (JL)

Department of Psychiatry, Hospital "Virgen de la Luz", Cuenca, Spain.

Manuel Arrojo (M)

Department of Psychiatry, Psychiatric Genetic Group, Instituto de Investigación Sanitaria de Santiago de Compostela, Complejo Hospitalario Universitario de Santiago de Compostela, Santiago, Spain.

Mara Parellada (M)

Department of Child and Adolescent Psychiatry, Hospital General Universitario Gregorio Marañón, School of Medicine, Universidad Complutense, ISGM, CIBERSAM, Madrid, Spain.

Ilaria Tarricone (I)

Department of Biomedical and NeuroMotor Sciences, Psychiatry Unit, Alma Mater Studiorium Università di Bologna, Bologna, Italy.

Domenico Berardi (D)

Department of Biomedical and NeuroMotor Sciences, Psychiatry Unit, Alma Mater Studiorium Università di Bologna, Bologna, Italy.

Mirella Ruggeri (M)

Section of Psychiatry, Department of Neuroscience, Biomedicine and Movement, University of Verona, Verona, Italy.

Antonio Lasalvia (A)

Section of Psychiatry, Department of Neuroscience, Biomedicine and Movement, University of Verona, Verona, Italy.
Section of Psychiatry, Azienda Ospedaliera Universitaria Integrata di Verona, Verona, Italy.

Laura Ferraro (L)

Department of Experimental Biomedicine and Clinical Neuroscience, Section of Psychiatry, University of Palermo, Palermo, Italy.

Caterina La Cascia (C)

Department of Experimental Biomedicine and Clinical Neuroscience, Section of Psychiatry, University of Palermo, Palermo, Italy.

Daniele La Barbera (D)

Department of Experimental Biomedicine and Clinical Neuroscience, Section of Psychiatry, University of Palermo, Palermo, Italy.

Paulo Rossi Menezes (PR)

Department of Preventive Medicine, Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brazil.

Cristina Marta Del-Ben (CM)

Division of Psychiatry, Department of Neuroscience and Behaviour, Ribeirão Preto Medical School, Universidade de São Paulo, São Paulo, Brazil.

Bart P Rutten (BP)

Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University Medical Centre, Maastricht, The Netherlands.

Jim van Os (J)

Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University Medical Centre, Maastricht, The Netherlands.
Department of Psychiatry, Brain Center Rudolf Magnus, Utrecht University Medical Centre, Utrecht, The Netherlands.
Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, England.

Peter B Jones (PB)

Department of Psychiatry, University of Cambridge, Cambridge, England.
CAMEO Early Intervention Service, Cambridgeshire and Peterborough National Health Service Foundation Trust, Cambridge, England.

Robin M Murray (RM)

Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, England.

James B Kirkbride (JB)

PsyLife Group, Division of Psychiatry, University College London, London, England.

Craig Morgan (C)

Department of Health Services and Population Research, Institute of Psychiatry, Psychology and Neuroscience, King's College London, 16 De Crespigny Park, London, SE5 8AF, England. craig.morgan@kcl.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH